Literature DB >> 15206061

Antimicrobial-specific cell-mediated immune reconstitution in children with advanced human immunodeficiency virus infection receiving highly active antiretroviral therapy.

Adriana Weinberg1, Savita Pahwa, Rebecca Oyomopito, Vincent J Carey, Bonnie Zimmer, Lynne Mofenson, Andrea Kovacs, Sandra K Burchett.   

Abstract

To identify virological and immunological correlates of microbial-specific immune reconstitution in children with advanced human immunodeficiency virus (HIV) infection, Candida- and tetanus-specific lymphocyte proliferation was measured in 165 children initiating a new highly active antiretroviral therapy (HAART) regimen. During the study, the proportions of children with immunity to Candida and tetanus increased from 53% to 66% and 19% to 22%, respectively. Tetanus immunity was associated with an HIV load < or =400 RNA copies/mL and with Candida immunity. At the end of the study, 23% of the patients with baseline negative lymphocyte proliferation had tetanus immunity, and 65% had Candida immunity. Reconstitution of tetanus immunity correlated with lower end-of-study HIV loads and activated CD8+ cell percentages and higher baseline and in-study CD4+ cell percentages, but not with a gain of CD4+ cells. Reconstitution of Candida immunity showed similar trends. In conclusion, children with advanced HIV infection receiving HAART reconstituted Candida immunity more readily than they did tetanus immunity, suggesting a role for antigen reexposure. Additional factors for immune reconstitution were low HIV load, high CD4+ cell percentages, and low levels of activated CD8+ cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15206061     DOI: 10.1086/420931

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  8 in total

1.  Cellular and humoral immune responses to a tetanus toxoid booster in perinatally HIV-1-infected children and adolescents receiving highly active antiretroviral therapy (HAART).

Authors:  Natascha Ching; Jaime G Deville; Karin A Nielsen; Bonnie Ank; Lian S Wei; Myung Shin Sim; Steven M Wolinsky; Yvonne J Bryson
Journal:  Eur J Pediatr       Date:  2006-07-26       Impact factor: 3.183

2.  Continuous improvement in the immune system of HIV-infected children on prolonged antiretroviral therapy.

Authors:  Adriana Weinberg; Ruth Dickover; Paula Britto; Chengcheng Hu; Julie Patterson-Bartlett; Joyce Kraimer; Howard Gutzman; William T Shearer; Mobeen Rathore; Ross McKinney
Journal:  AIDS       Date:  2008-11-12       Impact factor: 4.177

3.  Short-term and long-term effects of highly active antiretroviral therapy on the incidence of herpes zoster in HIV-infected children.

Authors:  Myron J Levin; Jeffrey P Anderson; George R Seage; Paige L Williams
Journal:  J Acquir Immune Defic Syndr       Date:  2009-02-01       Impact factor: 3.731

4.  Impaired immunity to recall antigens and neoantigens in severely immunocompromised children and adolescents during the first year of effective highly active antiretroviral therapy.

Authors:  Mona Rigaud; William Borkowsky; Petronella Muresan; Adriana Weinberg; Phillip Larussa; Terry Fenton; Jennifer S Read; Patrick Jean-Philippe; Elaine Fergusson; Bonnie Zimmer; Dorothy Smith; Joyce Kraimer
Journal:  J Infect Dis       Date:  2008-10-15       Impact factor: 5.226

5.  Pneumocystis pneumonia in HIV-positive patients in Spain: epidemiology and environmental risk factors.

Authors:  Alejandro Alvaro-Meca; Ines Palomares-Sancho; Asuncion Diaz; Rosa Resino; Angel Gil De Miguel; Salvador Resino
Journal:  J Int AIDS Soc       Date:  2015-05-20       Impact factor: 5.396

6.  Effect of cytomegalovirus co-infection on normalization of selected T-cell subsets in children with perinatally acquired HIV infection treated with combination antiretroviral therapy.

Authors:  Suad Kapetanovic; Lisa Aaron; Grace Montepiedra; Patricia Anthony; Kasalyn Thuvamontolrat; Savita Pahwa; Sandra Burchett; Adriana Weinberg; Andrea Kovacs
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

7.  Determinants of vaccine immunogenicity in HIV-infected pregnant women: analysis of B and T cell responses to pandemic H1N1 monovalent vaccine.

Authors:  Adriana Weinberg; Petronella Muresan; Kelly M Richardson; Terence Fenton; Teresa Dominguez; Anthony Bloom; D Heather Watts; Mark J Abzug; Sharon A Nachman; Myron J Levin
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

8.  Rate of candidiasis among HIV-infected children in Spain in the era of highly active antiretroviral therapy (1997-2008).

Authors:  Alejandro Álvaro-Meca; Julia Jensen; Dariela Micheloud; Asunción Díaz; Dolores Gurbindo; Salvador Resino
Journal:  BMC Infect Dis       Date:  2013-03-04       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.